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Pneumatosis intestinalis (PI) is a radiologic ﬁnding associated with multiple conditions and a high
mortality rate (33e40%, 1e3). The current literature addressing PI is limited to an unselected population.
This is the ﬁrst study addressing the management of PI in cirrhotics, a population in which surgical
intervention is particularly risky. While nonoperative management is acceptable in the general popu-
lation, it is unknown whether the same is true when managing patients with underlying cirrhosis. We
retrospectively identiﬁed cases of PI found on computed tomography (CT) scans performed on cirrhotics
from 2004 to 2011. Chart review included comorbidities, hospital course, serum lactate levels, APACHE
scores and MELD scores. Nine cirrhotics with PI were identiﬁed. Eight were managed conservatively. One
patient with MELD score of 18 underwent exploration and died. In total, six patients died. The mean
MELD score in patients who died was higher than in those who survived (28 vs. 14). Mortality was 100%
in cirrhotic patients with PI whose MELD was greater than 16. Mean lactate levels (33 mg/dL vs. 21 mg/
dL) and mean APACHE scores (28 vs. 15) were also higher in those who died. Serum bicarbonate levels
and white blood cell counts were not consistently elevated. Our results suggest that the MELD score is an
important predictor of mortality in cirrhotics with PI. Serum lactate and APACHE scores are also
important markers. Larger studies are required to determine whether there is a role for operative
management in cirrhotic patients with a MELD lower than 16.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Pneumatosis intestinalis (PI) is a rare pathologic condition
deﬁned as the presence of gas within the submucosal and/or sub-
serosal layer of the bowel. First described in 1783 by German
pathologist DuVernoi, pneumatosis intestinalis is now predomi-
nantly identiﬁed radiologically. It can be seen on plain abdominal
ﬁlms, but is best identiﬁed on computed tomography (CT) scans,
where it may appear as primary pneumatosis cystoides intestinalis
with thin-walled cysts in the colon, or as a linear gas patternwithin
the viscus wall1 (Fig. 1).
Both forms of pneumatosis intestinalis have been associated
with a number of benign to life threatening conditions, althoughang), Karipinf@einstein.edu
ia), CAmposst@einstein.edu
), jorgeortiz2275@gmail.com
ciates Ltd. Published by Elsevier Ltcystoides is often described as benign.2 Possible etiologies include
benign pulmonary conditions such as asthma and bronchitis, sys-
temic immune disorders such as lupus, iatrogenic sources such as
endoscopy and anastomosis, and medications such as lactulose and
sorbitol. Life-threatening causes include bowel ischemia, mesen-
teric vascular disease, inﬂammation of bowel, and trauma.2 These
cases are often associated with concomitant CT ﬁndings, including
bowel wall thickening, vascular occlusion, portal or portomesen-
teric gas and ascites.2
To date, the vast majority of papers describing pneumatosis are
limited to case reports and small series in an unselected population.
Knechtle et al. studied 27 patients with CT ﬁndings of pneumatosis
and elevated serum lactic acid and found these factors to correlate
with mortality.3 Recently, a 2004 study with a much larger cohort
effectively demonstrated a similar correlation between elevated
lactate (>2 mml/L or 18 mg/dL) and a mortality rate of greater than
80% in the setting of pneumatosis intestinalis.4 Other studies have
suggested that the Acute Physiology and Chronic Health Evaluation
(APACHE) score is a useful predictor of mortality.5 While the
markers of mortality differ, most conclude that PI can and should bed. All rights reserved.
Fig. 1. Gas cysts in the bowel wall characteristic of PI.
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operative intervention is still unclear.
No studies have addressed the management of PI in cirrhotic
patients. The aim of this article is to describe our experience
managing 9 cirrhotic patients with radiologic ﬁndings of PI. To
determine which factors are associated with poorer outcomes in
our cohort, we examined established markers of prognosis and
surgical risk in cirrhotic patients such as the Model of End-Stage
Liver Disease (MELD),6 lactate and APACHE II scores.
2. Methods
After obtaining Institutional Review Board (IRB) approval, a retrospective review
was conducted at Albert Einstein Medical Center (Philadelphia, PA, USA) between
2004 and 2011. We performed a query on computed tomography (CT) dictations
using the terms “pneumatosis”, “cirrhosis” and “cirrhotic.” We then reviewed re-
cords of the list generated by the query to exclude subjects who did not have
radiologic ﬁndings of pneumatosis intestinalis or cirrhosis. This process led to a
series of ten cirrhotic patients with PI.
We collected demographic data, CT scan ﬁndings (bowel wall thickening,
vascular occlusion, portal/portomesenteric gas and ascites), administration of
medications associatedwith PI (steroids, lactulose, sorbitol, and voglibose), presence
of bacteremia, serum laboratory values (complete blood count, hepatic function
tests, and lactic acid) on admission, APACHE II scores (on admission and on entry to
the ICU), MELD scores, and mortality. Patients were divided into two groups for
statistical comparison, with patients who survived in one group and those who did
not survive in another group. Descriptive statistics was used to compare groups as
the number of subjects was too small for statistical analysis.
3. Results
Themean age of our patients was 32.18 years, ranging from 45 to
61 years of age. There were 5 males and 4 females. Six of the nine
patients died (67%). One subject underwent surgery and died.
Mean lactic acid level on admission for the survivor group was
20 mg/dL (range 19e29), and 33.2 mg/dL for the mortality group
(range 19.0e54.8 mg/dL). The mean lactic acid level on admission
to the ICU was 90.6 mg/dL for the mortality group. Lactic acid levels
on admission were not signiﬁcantly associated with mortality in
our cohort.
APACHE II scores were also calculated for admission labs and
upon transfer to a higher level of care in the intensive care unit.
(ICU) Mean APACHE II score on admission was 15 for the survivor
group. The mean APACHE II score on admission for the mortalitygroup was 17.6. However, on admission to the ICU, the mean
APACHE II score was 28.3 in the mortality group, indicating that
APACHE II scores among patients who required ICU-level care may
be associated with mortality.
Admission MELD scores were consistently higher in the mor-
tality group (mean 27.7, range 20e37) than the survivor group
(mean 14.3, range 11e17). Higher MELD scores were associated
with mortality in our cohort.
All cases of pneumatosis were identiﬁed radiologically in the
colon, with majority in the cecum and ascending colon (8/9, 88.9%).
No patients were found to have portal or portomesenteric gas on CT
scan. Splenomegaly (8/9) and portal hypertension (7/9), ﬁndings
consistent with a known diagnosis of cirrhosis, were found in the
majority of our patients. No patients had arterial occlusion. One
patient had avenous occlusion identiﬁed on CT. Another patient had
bowel mucosa enhancement consistent with inﬂammation. Both
abnormal CT ﬁndings were found in patients of themortality group.
4. Discussion
Since it was ﬁrst described over a century ago, pneumatosis has
been recognized with increased incidence due to increased utili-
zation of computed tomography. The proposed pathogenesis and
clinical signiﬁcance of pneumatosis and its associationwith various
comorbidities have been diverse.1
Our series is the only one to date that describes pneumatosis
intestinalis in the cirrhotic patient population. Our experience
supports prior observations regarding the outcome of pneumatosis.
Our overall mortality rate of 66% is higher than the 22% previously
reported in the literature.4 Tanaka found the standardized mor-
tality ratio for cirrhotics for all causes of death combined was
increased 12-fold, with a relative 1-year survival rate of 67%.7 We
attribute some of this discrepancy to the poor overall survival of
cirrhotic patients and the small power of the series.
Lactate scores were not predictive of mortality in our series of
cirrhotic patients. This ﬁnding is likely due to our small sample size.
In our data, patients in the mortality group with a lactate level of
90.6 mg/dL on admission to the ICU reﬂect its importance as a
prognostic indicator.
APACHE II scores were also predictive of mortality in our series
of cirrhotic patients admitted to the ICU. This is congruent with the
underlying use of the APACHE scoring system, which is designed to
evaluate critically ill patients. Our ﬁndings conﬁrm Morris’ con-
clusions regarding the predictive value of the APACHE score for
pneumatosis intestinalis outcomes in an unselected patient
population.5
The MELD score has been demonstrated as a superior predictor
of 3-month mortality in cirrhotic patients.6 Our experience appears
to support the literature, and demonstrates that MELD on admis-
sion may be the most consistent predictor of outcome of patients
discovered to have pneumatosis intestinalis during their hospital
course.
In our series, all patients with a MELD score greater than 16 who
were medically treated had 100% mortality. In the literature, a
MELD score of 15 or greater is associated with a 1-year mortality of
17.4%.8 Operative intervention in such patients is associated with a
30-day mortality of approximately 60%.9 While conservative
management is generally accepted ﬁrst line treatment for patients
with PI, our experience suggests that given the underlying high
mortality of cirrhotics with PI, if there is an appropriate time for
intervention, it would be early in the disease course in patients
with MELD scores less than 16. In patients with MELD scores
greater than 16, or who have already begun to suffer the deleterious
effects of PI later in the disease course, it is unlikely that operative
management will provide any survival beneﬁt.
Table 1
Demographic and prognostic indicators (n ¼ 9).
Variable PI leading to death
(n ¼ 6)
PI leading to recovery
(n ¼ 3)
Gender (M,F) 4,2 1,2
Race (B,H,W) 3,1,2 1,0,2
Age 30.27 (8.34) 36 (10)
BMI 53.27 (3.9) 56.39 (5.25)
Lactulose use 6 2
Length of stay 27.33(36.38) 9 (2.64)
MELD, median 28 (6) 14 (3)
Lactate level 33.23 (13.23) 20.83 (2.84)
APACHE score 17.66 (6.5) 15.33 (6.02)
M ¼ male, F ¼ female.
B ¼ Black, H ¼ Hispanic, W ¼White.
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were treated purely with nonoperative management, making it
possible to more closely compare outcomes not confounded by
intervention. Weaknesses include the small sample size, which
make it difﬁcult to draw any conclusions other than observed
trends. We recognize that while using MELD to predict mortality in
cirrhotics has been clearly demonstrated, our small experience
with PI and the noted trend with MELD is purely observational. We
do not correct for variables that may confound a correlation, and
suggest that larger studies are required to better conﬁrm such a
correlation, and also determinewhether there is a role for operative
management in cirrhotic patients with a MELD lower than 16.
In conclusion, MELD, APACHE II, and lactic acid are appropriate
prognostic factors in cirrhotic patients with PI. Based on our
experience, there may be a role for early operative management in
cirrhotic patients with PI whose MELD is less than 16. As with other
illnesses that carry a high morbidity and mortality, it is crucial to
inform patients and families of the high mortality rate of PI in the
cirrhotic population. This may avoid emergent surgeries among
patients with overall high mortality (Table 1).Ethical approval
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